Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,501 | 1,380 | 99.9% |
| Education | $11.80 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,471 | 214 | $0 (2024) |
| ABBVIE INC. | $2,242 | 134 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,240 | 136 | $0 (2024) |
| Novo Nordisk Inc | $1,803 | 101 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,544 | 134 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,383 | 87 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,164 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $831.13 | 44 | $0 (2024) |
| Amarin Pharma Inc. | $810.21 | 42 | $0 (2022) |
| BioDelivery Sciences International, Inc. | $550.38 | 63 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,761 | 82 | Novo Nordisk Inc ($286.60) |
| 2023 | $2,540 | 138 | Novo Nordisk Inc ($462.39) |
| 2022 | $2,467 | 152 | ABBVIE INC. ($476.27) |
| 2021 | $3,781 | 272 | PFIZER INC. ($535.54) |
| 2020 | $2,495 | 178 | PFIZER INC. ($448.64) |
| 2019 | $2,817 | 189 | AstraZeneca Pharmaceuticals LP ($409.53) |
| 2018 | $2,248 | 179 | AstraZeneca Pharmaceuticals LP ($413.24) |
| 2017 | $2,404 | 192 | AstraZeneca Pharmaceuticals LP ($469.56) |
All Payment Transactions
1,382 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Opioid Analgesic | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: PAIN | ||||||
| 10/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: PAIN | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: Opioid Analgesic | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 484 | 745 | $117,748 | $48,823 |
| 2022 | 6 | 371 | 545 | $88,819 | $36,633 |
| 2021 | 5 | 350 | 507 | $88,813 | $37,945 |
| 2020 | 9 | 477 | 712 | $120,228 | $43,969 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 226 | $50,624 | $18,177 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $23,085 | $12,340 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 179 | $27,029 | $10,228 | 37.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 14 | $6,734 | $3,129 | 46.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 38 | 53 | $4,346 | $2,117 | 48.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 52 | 110 | $2,530 | $1,009 | 39.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,643 | $941.10 | 57.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,325 | $784.25 | 59.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $432.00 | $97.54 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 270 | $40,770 | $14,282 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $23,085 | $12,838 | 55.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 94 | $21,056 | $7,549 | 35.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 20 | 20 | $1,640 | $817.25 | 49.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,325 | $765.87 | 57.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 31 | 41 | $943.00 | $382.16 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 147 | 283 | $42,733 | $15,804 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 107 | 107 | $26,001 | $14,760 | 56.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 83 | $18,592 | $6,741 | 36.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 21 | 21 | $798.00 | $410.55 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $689.00 | $230.39 | 33.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 167 | 380 | $57,380 | $16,931 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 103 | 103 | $25,029 | $12,424 | 49.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 71 | $15,904 | $4,894 | 30.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 19 | 19 | $6,802 | $3,384 | 49.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 30 | 30 | $5,280 | $2,458 | 46.6% |
About Dr. John Corsi, DO
Dr. John Corsi, DO is a Internal Medicine healthcare provider based in Smithfield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689685042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Corsi, DO has received a total of $20,513 in payments from pharmaceutical and medical device companies, with $1,761 received in 2024. These payments were reported across 1,382 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($20,501).
As a Medicare-enrolled provider, Corsi has provided services to 1,682 Medicare beneficiaries, totaling 2,509 services with total Medicare billing of $167,370. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Smithfield, RI
- Active Since 08/11/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689685042
Products in Payments
- XTAMPZA (Drug) $1,461
- XARELTO (Drug) $1,278
- Ozempic (Drug) $901.81
- SYMBICORT (Drug) $860.28
- Vascepa (Drug) $810.21
- FARXIGA (Drug) $806.98
- TRELEGY ELLIPTA (Drug) $804.33
- ELIQUIS (Drug) $726.39
- CHANTIX (Drug) $692.88
- UBRELVY (Drug) $588.16
- Rybelsus (Drug) $575.54
- SYNTHROID (Drug) $543.15
- BELBUCA (Drug) $355.65
- STIOLTO RESPIMAT (Drug) $348.28
- Cologuard Collection Kit (Device) $325.11
- TRINTELLIX (Drug) $323.48
- NURTEC ODT (Drug) $317.41
- MYDAYIS (Drug) $273.65
- VRAYLAR (Drug) $265.30
- Androgel (Drug) $247.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Smithfield
Dr. Mateen Akhtar, M.d, M.D
Internal Medicine — Payments: $70,407
Dr. Matthew Hook, Md, MD
Internal Medicine — Payments: $16,267
Dr. Shubi Shahida, Md, MD
Internal Medicine — Payments: $13,515
Shannon Pope, Md, MD
Internal Medicine — Payments: $7,734
Dr. Eric Janis, M.d, M.D
Internal Medicine — Payments: $7,312
Dr. Jarmella Russell, M.d, M.D
Internal Medicine — Payments: $5,600